Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Jeffrey Meyerhardt, MD, MPH, answers common questions about treatment and research, family history, and ways that you can reduce your risk.
The test was able to identify many cancers, and their location, at early stages.
Though small, the increased risk prompted researchers to urge more cautious prescribing.
I continue to see this second remission as an oasis. This inner space is finite and precious.
Some of the most common and deadly cancers receive little attention and resources.
No photos can do this geography justice. Canada is so vast, so varied, so storied, so astonishing.
The study’s findings open a window for very early detection of the disease and could help identify those who need more aggressive treatment.
We talk about it all, from this cancer thing that’s kept me busy the last few years to revealing my high school crush.
Braftovi, Mektovi and Erbitux improved outcomes for those with advanced colorectal cancer with BRAF mutation.
This held true regardless of whether statins were taken before or after the cancer diagnosis.
I know one thing — I will enjoy this break as much as I can, floating on the knowledge of my hard-won temporary safety.
Men who ate yogurt at least twice a week were 26% less likely to have polyps with the potential to become malignant.
I sit down to discuss colon cancer and the One Percent Podcast with survivor Truitt Taylor.
But much needs to be done to help cancer survivors live longer and healthier lives.
Hugo Toovey, self-proclaimed “one but, half a gut,” founded 25StayAlive to encourage young people to be proactive with their health.
Robin McGee, PhD, 57, a clinical psychologist and patient advocate, lives in Nova Scotia with her spouse.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.